… shown to reduce COVID-19–associated death. Here, we provide a review of the potential
therapeutic agents being considered for the treatment and management of COVID-19 patients. …

… followed to avoid the transmission of coronavirus. RT-PCR and … As of now, antiviral therapy,
symptomatic and oxygen therapy … and nano based approaches for COVID-19 therapeutics. …

… in COVID-19-associated CS. We will particularly emphasize the role of GM-CSF and G-CSF
cytokines and other emerging therapeutic strategies adopted to mitigate COVID-19. …

… the pathogenesis of COVID-19. Both the virus and host factors are potential targets for
antiviral therapy. Hence, in this study, the current therapeutic strategies of COVID-19 have been …

… In this manuscript, we review primarily therapeutic and vaccinations for COVID-19. We
discuss therapeutic development strategies, the efficiency of developed drugs, vaccine …

… Currently there is no clinically approved antiviral drug or vaccine against COVID-19. The …
the prospects for studying peptides as potential drugs for the complex therapy of COVID-19. …

… provide new therapies for coronavirus disease abbreviated as COVID-19. The rational drug
… Targetting through ACEIs/ARBs offers an interesting prospects for inhibiting virus entry. In …

… The purpose of this article is to review the advancements and prospects of authorized COVID-19
… the investigational therapeutics options for the management of patients with COVID-19. …

… Looking for a new promising target in COVID-19 treatment, the authors focus their attention …
to COVID-19 therapy. Conclusion: as of now, there are no drugs which efficacy for COVID 19 …

… status of therapeutic candidates that have been examined for COVID-19 management, …
the current challenges and future prospect of developing potent therapeutic agents against …